Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity-Reference-Cited by-同舟云学术

Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity

Published:2021-11-18 Issue: Volume: Page:
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Mazzu Ying Z¹^ORCID,Liao YuRou¹,Nandakumar Subhiksha²,Sjöström Martin³⁴,Jehane Lina E.¹,Ghale Romina¹,Govindarajan Barani⁵,Gerke Travis A⁶,Lee Gwo‐Shu Mary⁷,Luo Jian‐Hua⁸,Chinni Sreenivasa R.⁵,Mucci Lorelei A⁹,Feng Felix Y³¹⁰⁴¹¹,Kantoff Philip W¹

Affiliation:

1. Department of Medicine Memorial Sloan Kettering Cancer Center New York NY USA

2. Center for Molecular Oncology Memorial Sloan Kettering Cancer Center New York NY USA

3. Department of Radiation Oncology University of California San Francisco San Francisco CA USA

4. Division of Hematology and Oncology Department of Medicine University of California San Francisco San Francisco CA USA

5. Department of Pathology Wayne State University Detroit MI USA

6. Prostate Cancer Clinical Trials Consortium New York NY USA

7. Department of Medicine Dana‐Farber Cancer Institute Boston MA USA

8. Department of Pathology University of Pittsburgh School of Medicine Pittsburgh PA USA

9. Department of Epidemiology Harvard T.H. Chan School of Public Health Boston MA USA

10. Helen Diller Family Comprehensive Cancer Center University of California San Francisco San Francisco CA USA

11. Department of Urology University of California San Francisco San Francisco CA USA

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13140

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. YTHDF3 Regulates the Degradation and Stability of m6A‐Enriched Transcripts to Facilitate the Progression of Castration‐Resistant Prostate Cancer;Journal of Pineal Research;2024-08

2. Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer;Cell Death & Differentiation;2024-04-23

3. Regulation of Hippo-YAP/CTGF signaling by combining an HDAC inhibitor and 5-fluorouracil in gastric cancer cells;Toxicology and Applied Pharmacology;2024-01

4. Radiotranscriptomics identified new mRNAs and miRNA markers for distinguishing prostate cancer from benign prostatic hyperplasia;Cancer Medicine;2023-11-21

5. Tensin 1 regulated by hepatic leukemia factor represses the progression of prostate cancer;Mutagenesis;2023-09-15